Bifogade filer
PDF
Kurs
+1,65%
Likviditet
10,2 MNOK
Kalender
| Est. tid* | ||
| 2025-11-06 | 07:00 | Kvartalsrapport 2025-Q3 |
| 2025-08-14 | 07:00 | Kvartalsrapport 2025-Q2 |
| 2025-05-28 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
| 2025-05-27 | - | Årsstämma |
| 2025-05-08 | - | Kvartalsrapport 2025-Q1 |
| 2025-02-13 | - | Bokslutskommuniké 2024 |
| 2024-11-06 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-22 | - | Kvartalsrapport 2024-Q2 |
| 2024-06-26 | - | Årsstämma |
| 2024-06-06 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
| 2024-05-08 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-01 | - | Bokslutskommuniké 2023 |
| 2023-11-02 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-17 | - | Kvartalsrapport 2023-Q2 |
| 2023-06-07 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
| 2023-06-06 | - | Årsstämma |
| 2023-05-04 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-02 | - | Bokslutskommuniké 2022 |
| 2022-10-27 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-18 | - | Kvartalsrapport 2022-Q2 |
| 2022-06-23 | - | Årsstämma |
| 2022-05-27 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
| 2022-04-28 | - | Kvartalsrapport 2022-Q1 |
| 2022-01-27 | - | Bokslutskommuniké 2021 |
| 2021-10-28 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-19 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-21 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
| 2021-05-20 | - | Årsstämma |
| 2021-04-22 | - | Kvartalsrapport 2021-Q1 |
| 2021-01-28 | - | Bokslutskommuniké 2020 |
| 2020-10-22 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-19 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-15 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
| 2020-05-14 | - | Årsstämma |
| 2020-04-23 | - | Kvartalsrapport 2020-Q1 |
| 2020-01-30 | - | Bokslutskommuniké 2019 |
| 2020-01-06 | - | Extra Bolagsstämma 2020 |
| 2019-10-24 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-15 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-16 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
| 2019-05-15 | - | Årsstämma |
| 2019-04-30 | - | Kvartalsrapport 2019-Q1 |
| 2019-01-30 | - | Bokslutskommuniké 2018 |
| 2018-10-18 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-16 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-09 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
| 2018-05-07 | - | Årsstämma |
| 2018-04-26 | - | Kvartalsrapport 2018-Q1 |
| 2018-02-01 | - | Bokslutskommuniké 2017 |
| 2017-10-19 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-17 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-12 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
| 2017-05-11 | - | Årsstämma |
| 2017-04-27 | - | Kvartalsrapport 2017-Q1 |
| 2017-02-02 | - | Bokslutskommuniké 2016 |
| 2016-10-26 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-17 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-12 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
| 2016-05-11 | - | Årsstämma |
| 2016-04-19 | - | Kvartalsrapport 2016-Q1 |
| 2016-02-11 | - | Kapitalmarknadsdag 2016 |
| 2016-02-11 | - | Bokslutskommuniké 2015 |
| 2015-11-03 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-13 | - | Kvartalsrapport 2015-Q2 |
| 2015-05-13 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
| 2015-05-12 | - | Årsstämma |
| 2015-05-05 | - | Kvartalsrapport 2015-Q1 |
| 2015-02-17 | - | Bokslutskommuniké 2014 |
| 2014-11-05 | - | Kvartalsrapport 2014-Q3 |
| 2014-08-13 | - | Kvartalsrapport 2014-Q2 |
| 2014-05-15 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
| 2014-05-14 | - | Årsstämma |
| 2014-04-30 | - | Kvartalsrapport 2014-Q1 |
| 2014-02-14 | - | Bokslutskommuniké 2013 |
| 2013-11-01 | - | Kvartalsrapport 2013-Q3 |
| 2013-08-09 | - | Kvartalsrapport 2013-Q2 |
| 2013-06-13 | - | Kapitalmarknadsdag 2013 |
| 2013-05-28 | - | X-dag ordinarie utdelning |
| 2013-05-27 | - | Årsstämma |
| 2013-05-07 | - | Kvartalsrapport 2013-Q1 |
| 2013-02-01 | - | Extra Bolagsstämma 2013 |
| 2013-01-07 | - | Bokslutskommuniké 2012 |
| 2012-11-06 | - | Kvartalsrapport 2012-Q3 |
| 2012-08-10 | - | Kvartalsrapport 2012-Q2 |
| 2012-05-07 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
| 2012-05-07 | - | Årsstämma |
| 2012-05-07 | - | Kvartalsrapport 2012-Q1 |
| 2012-02-21 | - | Bokslutskommuniké 2011 |
| 2011-11-08 | - | Kvartalsrapport 2011-Q3 |
| 2011-08-10 | - | Kvartalsrapport 2011-Q2 |
| 2011-05-13 | - | Årsstämma |
| 2011-05-13 | - | Kvartalsrapport 2011-Q1 |
| 2011-05-12 | - | X-dag ordinarie utdelning |
| 2011-02-17 | - | Bokslutskommuniké 2010 |
| 2010-11-12 | - | Kvartalsrapport 2010-Q3 |
| 2010-08-10 | - | Kvartalsrapport 2010-Q2 |
| 2010-05-11 | - | Kvartalsrapport 2010-Q1 |
| 2010-05-04 | - | Årsstämma |
| 2010-03-03 | - | Bokslutskommuniké 2009 |
Beskrivning
| Land | Norge |
|---|---|
| Lista | Oslo Bors |
| Sektor | Hälsovård |
| Industri | Bioteknik |
Tromsø, Norway, 30[th] June 2021 - ArcticZymes Technologies ASA (OSE: AZT) announces the launch of the second generation of its SAN HQ enzyme
ArcticZymes Technologies' Salt Active Nuclease High Quality (SAN HQ) enzyme has achieved significant penetration in the viral vector manufacturing space in the last 5 years. Viral vectors are used in therapeutic applications such as vaccines and gene therapies. SAN HQ treatment is used in the downstream purification of viral vectors to remove contaminating DNA.
The second generation of the enzyme, SAN HQ 2.0, has been optimised for wider compatibility with downstream processes used in biomanufacturing. In particular, SAN HQ 2.0 offers improved resolution in several chromatographic techniques, thereby simplifying the separation of the nuclease from the target product post treatment. ArcticZymes anticipates that SAN HQ 2.0 will increase the Company's reach within the viral vector space and provide new opportunities in recombinant protein production.
The product will be commercially available from late Q3 2021.
For more information, please contact:
CEO, Jethro Holter Tel: +47 46 85 91 46
CFO, Børge Sørvoll Tel: +47 95 29 01 87
ir@arcticzymes.com
About ArcticZymes Technologies ASA
ArcticZymes Technologies is a Norwegian life sciences company focused on the development, manufacturing and commercialization of novel recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and therapeutics.
Listed on the Oslo Stock Exchange since 2005 originally under the [Biotec] ticker, as Biotec Pharmacon. The company rebranded as ArcticZymes Technologies in 2020 under the [AZT] ticker. Its headquarters are based in Tromsø, Norway, at the SIVA Innovation Centre.
ArcticZymes Technologies' IP and capabilities are protected via a large portfolio of patents.
For more information, please visit the website: www.arcticzymes.com.